NCT05219994View on ClinicalTrials.gov

Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

May 10, 2023

Study Completion Date

May 10, 2023

Conditions
Type 2 Diabetes
Interventions
OTHER

Hyperoxia Exposure

2 hours of hyperoxia exposure during OGTT

OTHER

Normoxia Exposure

2 hours of normoxia exposure during OGTT

Trial Locations (1)

65211

University of Missouri, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum | Biotech Hunter | Biotech Hunter